Is Congress About to Reduce Funding for Bioterrorism Vaccines?
• io9.comIn 2004, Congress passed the Project BioShield Act—a ten-year, $5.6 billion fund for purchasing vaccines to use in the event of a bioterrorist attack.
In 2004, Congress passed the Project BioShield Act—a ten-year, $5.6 billion fund for purchasing vaccines to use in the event of a bioterrorist attack.
